Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors
Human Pathology Dec 06, 2019
Terra SBSP, et al. - Resected pulmonary carcinoid tumors (PCT) (1997-2017) were analyzed in order to examine alpha-thalassemia/mental retardation syndrome X-linked (ATRX) expression in PCT and its diagnostic and prognostic role in these people. Whilst adjusted for lymphovascular invasion and perineural invasion, loss of ATRX expression was related to atypical PCTs. Following adjusting for lymphovascular invasion and the presence of metastatic disease at the time of diagnosis, loss of ATRX expression was correlated with shorter disease-specific survival. Via two reviewers, interobserver agreement on ATRX expression was important. Thus, ATRX expression is more generally lost in atypical vs typical PCT and is related to more aggressive tumor features and shorter disease-specific survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries